The preparation of the potential magnetic resonance imaging (MRI) tumarselective contrast agent manganese meso-tetra(4-sulfonatophenyl)porphine (MnTPPS4) was optimized to yield a product with high purity (k!X3%) in large amounts (z= 1 g). The presented simplified purification method may contribute t
A comparative study of manganese meso-sulfonatophenyl porphyrins: Contrast-enhancing agents for tumors
β Scribed by R.J. Fiel; D.A. Musser; E.H. Mark; R. Mazurchuk; J.J. Alletto
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 830 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0730-725X
No coin nor oath required. For personal study only.
β¦ Synopsis
Four manganese meso-sulfonatophenyl porphyrins were prepared, characterized and investigated for their potential as tumor-specific MRI contrast-enhancing agents in mice bearing subcutaneous implants of a mammary carcinoma (SMT-F). The trisulfonated tetraphenyl porphyrin, MnTPPS3 presented the most favorable profile: bio-distribution, tumor concentration and tumor relaxivity, when compared at 24 hr postinjection. Imaging experiments revealed that a time-dependent delineation of tumor morphology occurs in response to MnTPPS3 that appears to correlate with necrotic regions of the tumor.
π SIMILAR VOLUMES
## Abstract ## Purpose To examine whether parameters of dynamic, contrastβenhanced MRI (DCE MRI) reflect the degree of infiltration and vessel density in corresponding bone marrow biopsy specimens. ## Materials and Methods The pelvis of 24 patients with multiple myeloma (MM) was examined using c
## Abstract T~1~βweighted magnetic resonance imaging (MRI) was used to evaluate the potential interest of a new Gdβbased contrast agent, termed P760, to characterize brain tumor heterogeneity and vascularization and to delineate regions containing permeable vessels. The C6 rat glioma model was used